Skip to main content
Article

Cervical cancer screening and prevention in Kazakhstan and Central Asia

Gulzhanat AimagambetovaDepartment of Biomedical Sciences, Nazarbayev University School of Medicine, Astana, KazakhstanChee Kai ChanDepartment of Biomedical Sciences, Nazarbayev University School of Medicine, Astana, KazakhstanTalshyn UkybassovaUniversity Medical Center, National Research Center for Mother and Child Health, Astana, KazakhstanBalkenzhe ImankulovaAskhat BalykovRegional Perinatal Center, Aktobe, KazakhstanKuralay KongrtayDepartment of Biomedical Sciences, Nazarbayev University School of Medicine, Astana, KazakhstanAzliyati AzizanDepartment of Biomedical Sciences, Nazarbayev University School of Medicine, Astana, Kazakhstan
2020en
ABI

Abstract

OBJECTIVE: To examine the state of cervical screening and prevention in Central Asian states, specifically Kazakhstan. RESULTS: In the five Central Asian countries that were formerly part of the Soviet Union (Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan), cervical cancer incidence and mortality rates are far higher than those in most Western and high-income nations, and are increasing. Cervical cancer screening is available in all five countries, but is mainly opportunistic. Only Kazakhstan has a structured cytological screening program, from which screening coverage analysis is possible. CONCLUSION: Despite significant decreases in cervical cancer incidence and mortality in developed countries, the problem is still of great concern in these Central Asian countries and is attributed to poorly organized screening and the absence of vaccination programs.

Identifiers

Citations and references

Cited by 40 references